Evidence map›Paper›PMID 42470394›Full record

ArticleACS infectious diseases2026

Random Forest Modeling to Predict Small Molecule Accumulation in Gram-Negative Bacteria.

Blake R Levy, Paul J Hergenrother

Abstract read
In one paragraph

Article in ACS infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Blake R LevyDepartment of Chemistry, University of Illinois Urbana-Champaign, Urbana61801, Illinois, United States.
Paul J HergenrotherDepartment of Chemistry, University of Illinois Urbana-Champaign, Urbana61801, Illinois, United States.ORCID 0000-0001-9018-3581

Funding

Discovering accumulation guidelines and applying them to develop new antibiotics for Gram-negative pathogensR01AI191595 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Paul Hergenrother · 2025 to 2026
$2.3M
National Institutes of Health (NIH) R01AI191595NIAID NIH HHS R01 AI191595University of Illinois at Urbana-Champaign NA
6 · The paper itself

Abstract

Despite extensive efforts over the past ∼60 years to discover new classes of Gram-negative-active antibiotics, the development pipeline remains relatively dry. These failures can be largely ascribed to the complexity of the Gram-negative membranes and an inadequate understanding of physicochemical properties associated with compound permeation, efflux evasion, and overall accumulation in Gram-negative pathogens. Recent work using unbiased accumulation assays and advanced chemical descriptors has utilized machine learning algorithms, particularly random forest modeling, to correlate physicochemical properties of small molecules with accumulation. The ability of a random forest classifier to effectively process large data sets while still providing human-interpretable insight makes this model a valuable tool in accumulation data analysis. Here, we describe in detail a workflow reliant on random forest modeling to probe physicochemical trends linked to small molecule permeation and/or efflux liabilities in Gram-negative pathogens. Applications using random forest modeling have led to guidelines for small molecule accumulation in E. coli and P. aeruginosa that have resulted in multiple new Gram-negative-active antibiotics. Random forest modeling possesses several distinct advantages over other machine learning models for the purposes of identifying physicochemical trends in accumulation, and as such, provides valuable hypothesis-generating information for the study of small molecule accumulation in Gram-negative bacteria.

Indexed as

Anti-Bacterial AgentsGram-Negative BacteriaSmall Molecule LibrariesEscherichia coliMachine LearningPrediction AlgorithmsPseudomonas aeruginosaRandom ForestAnti-Bacterial AgentsSmall Molecule Librariesantibiotic permeationantimicrobial agentseffluxgram-negative bacteriamachine learningrandom forest model

Identifiers

PMID42470394
PMCPMC13417973

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.